View Post

New mammogram measures of breast cancer risk could revolutionise screening

In In The News by Barbara Jacoby

Source: University of Melbourne From: eurekalert.org World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost. Published in the International Journal of Cancer, the University of Melbourne-led study found two new mammogram-based measures of risk. When these measures are combined, …

View Post

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

In In The News by Barbara Jacoby

By: Sharon Worcester From: medscape.com Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global cancer burden estimates from the International Agency for Research on Cancer (IARC). Breast cancer among women accounted for 11.7% of the estimated 19.3 million new cancer cases in 2020 ― …

View Post

Education-Only, Exercise Intervention-Based Programs Helped Reduce Lymphedema Incidence and Increase Range of Motion in Affected Limbs of Patients Treated for Breast Cancer

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com An education-only and education plus sleeve compression/exercise intervention program were similarly effective in reducing lymphedema incidence in women with breast cancer 18 months following the surgical removal of one or more of their lymph nodes, according to data recently published in Cancer. Of note, the study results also indicated that women in the education plus …

View Post

AI-powered microscope could check cancer margins in minutes

In In The News by Barbara Jacoby

Source: Rice University From: rice.edu When surgeons remove cancer, one of the first questions is, “Did they get it all?” Researchers from Rice University and the University of Texas MD Anderson Cancer Center have created a new microscope that can quickly and inexpensively image large tissue sections, potentially during surgery, to find the answer. The microscope can rapidly image relatively …

View Post

FDA Approves Margetuximab-cmkb Plus Chemo in Pretreated Metastatic HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Kristi Rosa From: onclive.com The FDA has approved margetuximab-cmkb (Margenza) in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have previously received 2 or more anti-HER2 regimens, at least one of which for metastatic disease.1 The regulatory decision was based on findings from the phase 3 SOPHIA trial (NCT02492711), in which the …

View Post

Should All Breast Cancer Patients Receive Genetic Testing?

In In The News by Barbara Jacoby

By: Jaime Rosenberg From: ajmc.com Recent years have seen calls for genetic testing for all patients with breast cancer. A session at the 2020 San Antonio Breast Cancer Symposium reviewed the evidence for, and against, such testing. In light of the 30th anniversary of Mary-Claire King, PhD, mapping BRCA1, a session on the last day of the 2020 San Antonio …

View Post

Delaying Breast Cancer Care Due to COVID-19 Fears Could Have Serious Unintended Consequences

In In The News by Barbara Jacoby

Source: ProCure Proton Therapy Center From: prnewswire.com As the U.S. deals with a resurgence of COVID-19 spread, it’s understandable that attention is shifting back in the direction of precautions such as limiting interpersonal contacts. However, medical experts note that delaying critical healthcare, such as breast cancer treatment, could cost patients valuable time. Cancer screenings and mammograms are equally important for …

View Post

Good clinical outcomes only a part of breast cancer recovery

In In The News by Barbara Jacoby

From: sabcsmeetingnews.org Recovering from breast cancer means more than good clinical outcomes. The overarching goal is good quality of life, which means balancing clinical outcomes with treatment toxicities while preserving a positive body image, good sexual health and, for patients who want it, the opportunity for biological children. “Local therapy can cause pain and lymphedema while systemic treatment can cause …

View Post

Educational Session explores advances in treating ER positive breast cancer

In In The News by Barbara Jacoby

From: sabcsmeetingnews.org Estrogen receptor positive (ER+) breast cancers may represent the single largest unmet clinical need in the field. ER+ breast cancer, also called luminal breast cancer, was once considered the default type of breast cancer, said David A. Cameron, MD, MSc. “Luminal breast cancer is the commonest type of breast cancer we see worldwide, about three-quarters of all breast …

View Post

PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema

In In The News by Barbara Jacoby

From: businesswire.com Study will further evaluate safety and tolerability of LYT-100 and explore clinical efficacy endpoints in patients with breast-cancer related, upper limb secondary lymphedema Previously announced results from multiple ascending dose and food effect study in healthy volunteers demonstrated favorable tolerability and pharmacokinetic proof-of-concept for LYT-100 A separate Phase 2 study evaluating LYT-100 in Long COVID respiratory complications and …